Search

In the highest value deal yet seen for a preclinical pipeline, GlaxoSmithKline plc swooped on Domantis Ltd, paying £230 million cash for the six-year-old UK Medical Research Council spin out.

Access to a good university shapes the location of corporate R&D.

Responses to the pre-budget statement offer grudging praise and a few suggestions.

Chinese officials warn that people may be overestimating how much the country spends on R&D.

The European Space Agency wants to increase its interaction with European universities, research institutes and industry.

The UK Government's budget preview was an excuse to flood the place with a torrent of papers on science, engineering and technology.

Three reports, two commissioned by possible next premier Gordon Brown and one inspired by him provide a glimpse of the future shape of UK innovation policy.

Watertight protection is more important than the speed with which patents are granted, according to a survey of business and academia.

Danish biotech is on the rise and has outpaced its closest neighbour, Sweden, according to a study published last week.

The notorious MP3 site AllofMP3.com is still functioning – despite the US–Russian agreement on intellectual property.

Just few days after the announcement of cut in its biology budget, France’s leading public research organisation is going flat out for industrial contracts.

Political naivety and national protectionism were blamed for quashing the latest attempt to forge a single patent regime for the European Union.